Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05389462
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2022-05-20
Brief Title:
A Study of Mipasetamab Uzoptirine ADCT-601 in Participants With Solid Tumors
Sponsor:
ADC Therapeutics SA
Organization:
ADC Therapeutics SA
Organization Data
Organization:
ADC Therapeutics SA
Class:
INDUSTRY
Study ID:
ADCT-601-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ADC Therapeutics SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None